ORIC Pharmaceuticals OverviewORIC Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for ORIC.
Quarterly Other Income/Expense
$3.85M
↑ 42.83% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$14.69M
↑ 6.72% YoY
Trailing 12 months ending Mar 31, 2026